A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  1996-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0360-3016(96)00352-5PMID 8948338
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Classification of gliomas and medulloblastomas using the new TNM system for cerebral tumors

  2005cited by this paper
• The management of histologically unverified presumed cerebral gliomas with radiotherapy.

  1995cited by this paper
• The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas

  1994cited by this paper
• The management of histologically unverified presumed cerebral gliomas with radiotherapy.

  1994cited by this paper
• Low grade supratentorial astrocytomas: Management and prognostic factors

  1994cited by this paper
• Low grade supratentorial astrocytomas. Management and prognostic factors

  1994cited by this paper
• Stereotactic irradiations on the horizon: a challenge for multimodal developments.

  1994cited by this paper
• Recurrent Low-Grade Gliomas: Dedifferentiation and Prospects of Reoperation

  1991cited by this paper
• Glioma : principles and practice in neuro-oncology

  1991cited by this paper
• Cure and Quality of Life After Treatment for Glioma

  1991cited by this paper
• Pitfalls and Controversies in the Treatment of Gliomas

  1991cited by this paper
• Radiation therapy in the management of low-grade supratentorial astrocytomas.

  1989cited by this paper
• Computer-assisted stereotaxic laser resection of intra-axial brain neoplasms.

  1986cited by this paper
• The value of radiation therapy in addition to surgery for astrocytomas of the adult cerebrum

  1985cited by this paper
• International Histological Classification of Tumours

  1981cited by this paper
• Dose Specification for Reporting External Beam Therapy with Photons and Electrons

  1979cited by this paper
• Treatment of grades I and II brain astrocytomas. The role of radiotherapy.

  1977cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Bevacizumab for the Management of Pediatric Radiation Necrosis: a Narrative Review

  2026cites this paper
• First Mexican consensus guideline for the management of IDH-mutant low-grade gliomas: Mexican guidelines for IDH-mutant gliomas

  2025influential citation
• Unlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomas

  2025cites this paper
• Radiotherapy guidelines for gliomas: 2025 update.

  2025cites this paper
• Low-grade IDH-mutant gliomas: from standard post-surgical treatments to novel IDH inhibitors

  2025cites this paper
• Management of Low-Grade Gliomas

  2025cites this paper
• Specific radiosensitivity of brain structures (areas or regions) and cognitive impairment after focal or whole brain radiotherapy: A review.

  2025cites this paper
• Expanded Use of Vorasidenib in Non-Enhancing Recurrent CNS WHO Grade 3 Oligodendroglioma

  2025cites this paper
• The Effects of Radiation Therapy on the Ocular Apparatus: Implications for Management

  2025cites this paper
• Analyzing the impact of proliferation and treatment parameters on low-grade glioma growth using mathematical models

  2025cites this paper
• Surgical outcomes in high-grade adult type diffuse gliomas (ATDG) with a previous diagnosis of anaplastic astrocytoma without adjuvant therapy.

  2025cites this paper
• Predictive non-molecular biomarkers of radiosensitivity in glioma: A review

  2025cites this paper
• Radiotherapeutic approaches in the treatment of adult gliomas.

  2025cites this paper
• Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma

  2024influential citation
• Brain volume loss after cranial irradiation: a controlled comparison study between photon vs proton radiotherapy for WHO grade 2–3 gliomas

  2024cites this paper
• Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma

  2024cites this paper
• A model-based risk-minimizing proton treatment planning concept for brain injury prevention in low-grade glioma patients.

  2024cites this paper
• Treatment of IDH-mutant glioma in the INDIGO era

  2024cites this paper
• ESTRO-EANO guideline on target delineation and radiotherapy for IDHmutant WHO CNS grade 2 and 3 diffuse glioma.

  2024cites this paper
• Treatment Options for IDH-Mutant Malignant Gliomas

  2024cites this paper
• Oncological Outcomes, Long-Term Toxicities, Quality of Life and Sexual Health after Pencil-Beam Scanning Proton Therapy in Patients with Low-Grade Glioma

  2023cites this paper
• Target Volume Definition in Radiation Oncology

  2023influential citation
• Analysis of Prognostic factors and Surgical Management of Elderly Patients with Low-Grade Gliomas.

  2023cites this paper
• Long-term treatment outcomes of temozolomide-based chemoradiation in patients with adult-type diffuse IDH-mutant grade 2 astrocytoma

  2023cites this paper
• Prediction of Tumor Development and Urine-Based Liquid Biopsy for Molecule-Targeted Therapy of Gliomas

  2023cites this paper
• Thirty years of progress in the management of low-grade gliomas.

  2023cites this paper
• Effectiveness and safety of different postoperative adjuvant regimens in patients with low-grade gliomas:A network meta-analysis.

  2023cites this paper
• The prognosis of gliomas with different molecular subtypes in the era of intensity-modulated radiation therapy (IMRT)

  2023cites this paper
• Tumor volume and calcifications as indicators for preoperative differentiation of grade II/III diffuse gliomas

  2023cites this paper
• Central Nervous System Tumors

  2022cites this paper
• Executive summary of american radium society's appropriate use criteria for the postoperative management of lower grade gliomas.

  2022cites this paper
• Low grade gliomas guide-lines elaborated by the tumor section of Spanish Society of Neurosurgery.

  2022cites this paper
• Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.

  2022cites this paper
• Consenso sobre guías de tratamiento de gliomas de bajo grado elaborado por el grupo de tumores de la SENEC

  2022cites this paper
• Nuclear medicine and radiotherapy in the clinical management of glioblastoma patients

  2022cites this paper
• Trends in radiation dose for low grade gliomas across the United States

  2022cites this paper
• Treatment of Adult Gliomas: A Current Update

  2022cites this paper
• Initial PCV Chemotherapy Followed by Radiotherapy Is Associated With a Prolonged Response But Late Neurotoxicity in 20 Diffuse Low-Grade Glioma Patients

  2022cites this paper
• Conventional and emerging treatments of astrocytomas and oligodendrogliomas

  2022cites this paper
• Magnetic Resonance-Guided Laser Interstitial Thermal Therapy for Management of Low-Grade Gliomas and Radiation Necrosis: A Single-Institution Case Series

  2022cites this paper
• Three-dimensional arterial spin labeling-guided dose painting radiotherapy for non-enhancing low-grade gliomas

  2022cites this paper
• Current and promising treatment strategies in glioma

  2022cites this paper
• World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas: A Review.

  2022cites this paper
• Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline.

  2022cites this paper
• Neutrophilia and post-radiation thrombocytopenia predict for poor prognosis in radiation-treated glioma patients

  2022cites this paper
• Modern surgical management of incidental gliomas

  2022cites this paper
• A Personalized Longitudinal Strategy in Low-Grade Glioma Patients: Predicting Oncological and Neural Interindividual Variability and Its Changes over Years to Think One Step Ahead

  2022cites this paper
• Radiation-induced contrast enhancement following proton radiotherapy for low-grade glioma depends on tumor characteristics and is rarer in children than adults.

  2022cites this paper
• From Laboratory Studies to Clinical Trials: Temozolomide Use in IDH-Mutant Gliomas

  2021cites this paper
• Prognostic significance of modified Pignatti score in patients with World Health Organization grade II diffuse astrocytomas

  2021cites this paper
• IDH-Mutant Low-grade Glioma: Advances in Molecular Diagnosis, Management, and Future Directions

  2021cites this paper
• Advances in Research of Adult Gliomas

  2021cites this paper
• IDH Inhibitors and Beyond: The Cornerstone of Targeted Glioma Treatment

  2021cites this paper
• Radiation induced contrast enhancement after proton beam therapy in patients with low grade glioma - how safe are protons?

  2021cites this paper
• Radiation guidelines for gliomas.

  2021cites this paper
• Clinically Validated Model Predicts the Effect of Intratumoral Heterogeneity on Overall Survival for Non-Small Cell Lung Cancer (NSCLC) Patients

  2021cites this paper
• Difuzní nízkostupňové gliomy

  2021cites this paper
• Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas

  2021cites this paper
• GAMMA KNIFE RADIOSURGERY AS PRIMARY TREATMENT OF LOW-GRADE BRAINSTEM GLIOMAS: A SYSTEMATIC REVIEW AND METANALYSIS OF CURRENT EVIDENCE AND PREDICTIVE FACTORS.

  2021cites this paper
• Update on Radiation Therapy for Central Nervous System Tumors.

  2021cites this paper
• High-dose radiotherapy in newly diagnosed low-grade gliomas with nonmethylated O(6)-methylguanine-DNA methyltransferase

  2021cites this paper
• Mathematical Modeling and Mutational Analysis Reveal Optimal Therapy to Prevent Malignant Transformation in Grade II IDH-Mutant Gliomas

  2021cites this paper
• Grade 2 Gliomas

  2021cites this paper
• The Evolving Role of Radiotherapy for Pediatric Cancers With Advancements in Molecular Tumor Characterization and Targeted Therapies

  2021cites this paper
• Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms.

  2021cites this paper
• A Study of Dose Painting Radiotherapy Guided by Three-Dimensional Arterial Spin labeling Perfusion Magnetic Resonance  Imaging for Non-Enhancing Low-Grade Gliomas

  2021cites this paper
• Molecular Markers of Gliomas to Predict Treatment and Prognosis: Current State and Future Directions

  2021cites this paper
• Treatment Outcomes and Prognostic Factors in Patients with Low-Grade Glioma

  2021cites this paper
• Upfront therapy of aggressive/high-risk low-grade glioma: single institution outcome analysis of temozolomide-based radio-chemotherapy and adjuvant chemotherapy.

  2021cites this paper
• 3D whole-brain metabolite imaging to improve characterization of low-to-intermediate grade gliomas

  2021cites this paper
• Impact of Seizures and Anti-epileptic Drug Use on Survival in Patients with World Health Organization Grade II Glioma

  2021cites this paper
• A Radiomics nomogram for preoperative predicting recurrence of low grade gliomas based on multiparametric MRI

  2021cites this paper
• What Does Quality of Care Mean in Lower-Grade Glioma Patients: A Precision Molecular-Based Management of the Tumor or an Individualized Medicine Centered on Patient’s Choices?

  2021cites this paper
• High-dose radiation associated with improved survival in IDH-wildtype low-grade glioma

  2021cites this paper
• Effects of brain radiotherapy on cognitive performance in adult low-grade glioma patients: A Systematic Review.

  2021cites this paper
• Néoformations intracrâniennes : gliomes de grade II

  2020cites this paper
• Modern Treatments for Gliomas Improve Outcome

  2020cites this paper
• "A prospective study of assessment of neurocognitive function in illiterate patients with gliomas treated with chemoradiation": Assessment of neurocognitive function in gliomas.

  2020cites this paper
• The Association Between Radiation Therapy Dose and Overall Survival in Patients With Intracranial Infiltrative Low-Grade Glioma Treated With Concurrent and/or Adjuvant Chemotherapy

  2020influential citation
• Early versus delayed postoperative radiotherapy for treatment of low-grade gliomas.

  2020cites this paper
• Neoformazioni intracraniche: gliomi di grado II

  2020cites this paper
• Cancer of the Central Nervous System

  2020cites this paper
• Pattern of failure in IDH mutated, low grade glioma after radiotherapy - implications for margin reduction.

  2020cites this paper
• Imaging Gliomas After Treatment: A Case-based Atlas

  2020cites this paper
• Does the dural resection bed need to be irradiated? Patterns of recurrence and implications for postoperative radiotherapy for temporal lobe gliomas.

  2020cites this paper
• Population-based studies of brain tumor surgery: surgical outcome and prognostic factors

  2020cites this paper
• NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Central Nervous System Cancers, Version 3.2020

  2020cites this paper
• A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma

  2020cites this paper
• Neuro-Oncology Practice Clinical Debate: Early treatment or observation for patients with newly diagnosed oligodendroglioma and small-volume residual disease.

  2020cites this paper
• Pattern of failure in IDH mutated, low grade glioma after radiotherapy – Implications for margin reduction

  2020cites this paper
• Radiotherapy in adult low-grade glioma: nationwide trends in treatment and outcomes

  2020cites this paper
• Staging and Target Volume Definition by Imaging in CNS Tumors

  2020cites this paper
• Simplified Perfusion Fraction from Diffusion-weighted Imaging in Preoperative Prediction of IDH1 Mutation in WHO Grade II–III Gliomas: Comparison with Dynamic Contrast-enhanced and Intravoxel Incoherent Motion MRI

  2020cites this paper
• Clinical Management of Diffuse Low-Grade Gliomas

  2020cites this paper
• The biological and clinical basis for early referral of low grade glioma patients to a surgical neuro-oncologist.

  2020cites this paper
• Radiation-induced brain injury: current concepts and therapeutic strategies targeting neuroinflammation.

  2020cites this paper
• Phase II Study of a Temozolomide-Based Chemo-radiotherapy Regimen for High Risk Low-Grade Gliomas: Long-term Results of Radiation Therapy Oncology Group (RTOG) 0424.

  2020cites this paper
• The Path Forward for Radiation Therapy in the Management of Low-Grade Gliomas.

  2020cites this paper
• Fundamentals of Radiation Oncology for Neurologic Imaging.

  2020cites this paper
• Molecular characteristics of diffuse lower grade gliomas: what neurosurgeons need to know

  2020cites this paper